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Synthesis of the 75K (75K indicates a molecular weight of 70,000 to 75,000)
DNA binding protein, an early virus-coded protein in adenovirus 2-infected KB
cells, and its regulation were studied by using a radioimmune precipitation
inhibition assay. The protein was first detected at 4 h postinfection and accumu-
lated at an exponential rate. An arrest of further synthesis (accumulation) was
observed at 10 to 11 h postinfection, coinciding with the onset of synthesis of late
virion proteins. In contrast, when the infected cells were treated with 25 ug of
arabinosyl cytosine per ml to block viral DNA replication, the synthesis of 75K
protein did not cease but continued for up to 36 h postinfection. The synthesis of
75K protein in cells after release from a cycloheximide block (2 to 9 h postinfec-
tion) was analyzed. Increased amounts of early adenovirus-specific mRNA accu-
mulate in infected cells during a cycloheximide block (Parsons and Green, 1971).
However, cycloheximide treatment did not produce increased levels of 75K pro-
tein, and an abrupt arrest of 75K protein formation was again observed at the
time of synthesis oflate virion proteins. Partition ofthe 75K protein between the
nuclear and cytoplasmic fractions during the course of infection was studied.
The 75K protein appeared first in the cytoplasm and then in the nucleus after a
slight lag. Accumulation ofthe 75K protein continued both in the cytoplasm and
nucleus, with higher levels being found in the cytoplasm.
Several virus-specific polypeptides that are
not viron components are synthesized in hu-
man cells infected with adenovirus 2 or 5 (Ad2,
Ad5). These new polypeptides were identified
by electrophoresis on sodium dodecyl sulfate-
polyacrylamide gels of extracts of infected cells
pulse labeled at early times after infection (1, 2,
9, 14, 15, 20). They range in size from 75,000 to
10,000 daltons, based on their migration in gels.
Only one of these early polypeptides with a
molecular weight of 70,000 to 75,000 (referred to
as 75K protein) has been purified to date. It
binds to single-stranded but not double-
stranded DNA and has been termed the "DNA
binding protein" (17, 18). The 75K proteins
coded by Ad2 and Ad5 have similar properties
and molecular weights (13). Use ofAd5 temper-
ature-sensitive mutants has indicated that the
75K protein is virus coded and is necessary for
viral DNA replication (19). The viral gene cod-
ing for it has been mapped, by the use of tem-
perature-sensitive mutants, in the EcoRl B
fragment of the adenovirus genome (T. Grod-
zicker, C. W. Anderson, and J. Sambrook,
personal communication). Another polypeptide
of molecular weight 45,000 elutes from DNA-
cellulose columns together with the 75K protein
and appears to be a degradation product of the
75K protein (13).
We have recently shown by radioimmune
precipitation and radioimmune precipitation
inhibition (RIPI) that the Ad2 75K protein is
virus specific (5). The method involved the use
of purified 3H-labeled 75K protein and its ho-
mologous antibody present in sera from ham-
sters immunized with extracts of Ad2-simian
virus 40-induced tumors (4, 5). We have now
developed the RIPI method for the accurate
quantitation of the 75K protein in order to
study its synthesis. The present communication
describes our findings on the synthesis of this
protein during infection and its modulation by
interference with DNA or protein syntheses.
MATERIALS AND METHODS
Isolation of labeled 75K protein. Labeled 75K
protein was isolated from Ad2-infected KB cells and
purified by DNA-cellulose chromatography as previ-
ously described (5, 17) with two modifications. We
found that the trailing edge of the 0.6 M peak elut-
ing from the DNA-cellulose column contained only
75K protein, whereas the leading edge of the peak
contained also the 45K protein. Fractions from the
trailing edge of the peak only were pooled and used
as the source of 75K protein for the RIPI assay. In
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addition, labeling was performed with [35S]methio-
nine instead of [3H]leucine, yielding preparations
with higher specific radioactivity. Infected cells
were incubated with 5 ,uCi of [35S]methionine per
ml (210 to 466 Ci/mmol) in methionine-free Eagle
minimal essential medium containing 5% horse se-
rum. M5S-labeled 75K protein was prepared monthly
to minimize radioactive decay.
Experimental infection of KB cells and prepara-
tion of cell extracts. Suspension cultures ofKB cells
were infected with purified Ad2 at a multiplicity of
200 PFU/cell as previously described (17). Infected
cells were maintained at a concentration of 3 x 105
cells/ml in Eagle minimal essential medium con-
taining 5% horse serum. To prepare whole-cell ex-
tracts for assay of 75K protein, 9 x 106 cells (30 ml)
were withdrawn at specified times and washed with
Ca2+- and Mg2+-free phosphate-buffered saline
(PBS). The cells were resuspended in 1 ml of PBS
containing 1% Triton X-100 and stored at -5 C.
Before assay, suspensions were disrupted for 3 min
at full power in a Raytheon DF-101 sonic oscillator
and clarified at 2,000 x g for 10 min at 4 C. The
supernatant fractions were collected for assay. For
the preparation of cytoplasmic and nuclear extracts,
washed samples of 9 x 106 cells were resuspended in
1 ml of PBS containing 1% Triton X-100 at room
temperature, and after 5 min nuclei and cytoplasm
were separated by centrifugation at 800 x g for 10
min. The nuclei were sonicated and clarified as de-
scribed for whole-cell extracts.
To prepare extracts for complement fixation tests,
10-ml samples of infected cells (3 x 106 cells) were
washed with PBS, resuspended in 0.5 ml of veronal
buffer (16), sonicated for 3 min, and clarified at 2,000
x g for 10 min. The supernatant fractions were
collected for assay.
RIPI. The double-antibody method for radioim-
mune precipitation of labeled purified 75K protein
and the source of antisera have been described (5).
In the RIPI assay, 10-,ug aliquots of immune ham-
ster immunoglobulin G (IgG) (supplemented with
70 ,ug of "carrier" normal hamster IgG) were prein-
cubated with various amounts of extracts of unla-
beled infected cells sampled at various times post-
infection to block antibody activity. Preincubation
was for 1 h at 37 C in PBS containing 1% Triton
X-100 (vol/vol) and 1% sodium deoxycholate (wt/
vol) in conical 0.75-ml centrifuge tubes (Sarstedt,
Princeton, N.J.). The final reaction volume was 200
A1l. Labeled 75K protein (10,000 counts/min) was
then added, and incubation was continued for 1 h.
Finally, 30 Al of goat serum antihamster IgG was
added, and the precipitates formed after 2 h of in-
cubation at 37 C were centrifuged, washed, and
counted as previously described (5). Background
precipitation values (obtained with 80 Ag of normal
hamster IgG) were subtracted in each determina-
tion. The degree of inhibition observed with ex-
tracts of unlabeled infected cells was calculated as
percentage of control by comparison with reactions
substituting PBS for cell extracts.
Titration of virion proteins in extracts of infected
cells by the complement fixation. The micro-com-
plement fixation test of Sever (16) was used for the
titration of virion proteins as previously described
(6). Eight units of goat antibody to purified Ad2
virions was used with 2 U of complement.
RESULTS
Quantitation of 75K protein in extracts of
infected cells by the RIPI assay. The RIPI
assay is one of the few methods available to
accurately measure early proteins present in
relatively low concentrations in infected cells.
We have developed a RIPI assay for quantitat-
ing intracellular 75K protein using 35S-labeled
75K protein and its homologous antibody from
hamsters immunized with extracts of tumors
induced by an Ad2-simian virus 40 hybrid. To
standardize the assay, a precipitation reaction
was performed first with increasing amounts of
immune hamster IgG and 10,000 counts/min of
35S-labeled 75K protein (Fig. 1A). Ten micro-
grams of immune IgG, which precipitated.
about one-half of the 10,000-counts/min input
(Fig. 1A), was used subsequently in the RIPI
assays as follows. Aliquots of 10 ug of immune
IgG, supplemented with 70 ,ug of normal IgG,
were preincubated with increasing volumes of
unlabeled infected cell extract for 1 h at 37 C.
35S-labeled 75K protein (10,000 counts/min) was
then added, the reaction mixtures were further
incubated, and the assay was continued as de-
scribed in Materials and Methods. A represent-
ative inhibition curve obtained with different
volumes of a 20-h infected cell extract is shown
in Fig. 1B. In this instance, 50% inhibition of
radioimmune precipitation was obtained with
1.03 ,tl of cell extract; the volume of extract
causing 50% inhibition is designated Vw. Quan-
titation of the 75K protein content in cell ex-
tracts is based upon the determination of V50
from curves obtained for the individual ex-
tracts, as described in Fig. 1B, using different
extract volumes. Since the amount of 75K pro-
tein present in the extract is inversely related
to V50, the 75K protein titer is therefore ex-
pressed in inhibitory units as 1/V50 x 100; mul-
tiplication by 100 is used to avoid fractional
values.
The fidelity of the RIPI assay was tested by
reconstruction reactions with known amounts
of unlabeled 75K protein. The 0.6 M eluate,
from a DNA-cellulose column, which is the
source for labeled 75K protein, contains also
unlabeled host components (Sugawara, Gilead,
and Green, unpublished data). Unlabeled 75K
protein was therefore purified from the 0.6 M
eluate to homogeneity (Sugawara, Gilead, and
Green, manuscript in preparation). Known
amounts of pure 75K protein were mixed with
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FIG. 1. Quantitation of the RIPI assay. (A) Standard precipitation curve of 35S-labeled 75K protein.
Aliquots of 75K protein (10,000 counts/min) were mixed with increasing amounts of immunoglobulin from
immunized hamsters (immune IgG), supplemented with IgG from normal hamsters (normal IgG) to give 80
pg oftotal IgG, in reaction mixtures containing PBS, 1% Triton X-100, and1% sodium deoxycholate. After 1 h
of incubation at 37 C, 30 4 ofgoat serum anti-hamster IgG was added and precipitates formed after 2 h of
incubation at 37 C were centrifuged, washed twice with PBS containing 1% Triton X-100 and 1% sodium
deoxycholate, dissolved in 0.25 M acetic acid, and counted in a scintillation spectrometer. Background
radioactivity due to nonspecific precipitation, measured with 80 pg ofnormal IgG alone, was subtracted. (B)
The RIPI assay. Increasing volumes ofa 20-h infected cell extract were preincubated with 70 pg of "carrier"
normal IgG and 10 pg ofimmune IgG, shown in (A) to precipitate 50% of the 10,000-counts/min input of 35S-
labeled 75K protein, for 1 h at 37 C in the buffer described in (A) . 35S-labeled 75Kprotein (10,000 counts/min)
was added, and incubation was continued for an additional 1 h at 37 C. Goat anti-hamster IgG (30 pd) was
added, and the precipitates formed after2 h at37 C were treated was described in (A). The background counts
per minute precipitated with 80 pg ofnormal IgG was subtracted, and the percentage ofcontrol was calculated
by comparison with a reaction mixture in which PBS was substituted for the infected-cell extract.
extracts ofuninfected KB cells (9 x 106 cells/ml)
prepared as described for infected cells. A plot
of the concentration of 75K protein in the ex-
tracts versus the inhibitory titer measured in
the RIPI test (1/V5,, x 100) was linear (Fig. 2),
even at low 75K protein concentrations. The
smallest detectable titer of 75K protein in in-
fected cell extract is 0.5 inhibitory units. One
unit corresponds to a concentration of 1.4 Ag of
75K protein per ml of extract, according to the
plot in Fig. 2. However, we have not used this
plot to convert the relative inhibitory titers into
actual 75K protein concentrations in this paper
since the reconstruction mixtures are not iden-
tical to extracts of infected cells. Purified 75K
protein shows a tendency to aggregate and may
be more prone to inactivation in the recon-
structed extracts than intracellular 75K protein
in extracts of infected cells.
Kinetics of synthesis of 75K protein in in-
fected cells in the absence and presence ofAra
C. The 75K protein is an early protein essential
for viral DNA replication (19). It is synthesized
before the onset of viral DNA replication, and
also when viral DNA synthesis is inhibited
with arabinosyl cytosine (Ara C) (17, 18). The
kinetics of accumulation of the 75K protein in
infected KB cells were examined (Fig. 3). It was
first detected at 4 h postinfection, and its syn-
thesis (accumulation) was exponential up to 11
h postinfection, at which time it stopped. There
was a slow decline in the amount of75K protein
after 11 h, perhaps due to lysis ofsome cells late
during productive infection or to inactivation of
75K protein molecules in vivo. In contrast, the
initial rate of accumulation of 75K protein in
Ara C-treated cells was much slower, but did
not exhibit the arrest observed in uninhibited
cultures (Fig. 3). The synthesis of 75K protein
continued up to 36 h postinfection, at which
time Ara C-treated cells accumulated four
times more 75K protein than the highest level
observed in uninhibited cultures.
Synthesis of 75K protein in cells after
release from a cycloheximide block and effect
of Ara C. Cells treated early after infection
with cycloheximide do not synthesize viral
DNA (18) and accumulate up to five times as
much early viral mRNA as untreated infected
cells (12). It was of interest to determine
whether increased levels of viral mRNA would
result in an accelerated accumulation of 75K
protein after release from inhibition. Two pairs
of cultures, A and B, were infected. One A
A
1O
80
B
Inn, 1 rwn
J. VIROL.
SYNTHESIS OF DNA BINDING PROTEIN 457
Z50
200
C-,
I-
L&J
-9
150
1oo[
50
n
140 120 100 80 60 40 20 0
UNITS (1/V5o x 100)
FIG. 2. Linearity of RIPI assay. A series of ex-
tracts containing known concentrations of 75K pro-
tein was prepared by adding different amounts of
purified unlabeled 75K protein to an extract of unin-
fected KB cells (9 x 106 cells per ml of extract). The
reconstructed extracts were assayed by the RIPI as-
say. The inhibitory titer measured in the assay (1/VW
x 100) was plotted against 75Kprotein concentration
(micrograms per milliliter of extract).
culture was treated with cycloheximide (25 Ag/
ml) at 2 h postinfection, and the otherA culture
served as control. At 9 h postinfection, both A
cultures were washed twice with warm medium
and incubated in fresh medium lacking inhibi-
tor. One B culture received 25 ,ug of cyclohexi-
mide per ml at 2 h postinfection, while the
other B culture received 25 ,g of Ara C per ml
at 1 h postinfection. Both B cultures were
washed twice at 9 h postinfection with warm
medium containing 25 jig of Ara C per ml and
incubated in medium containing 25 ug ofAra C
per ml. Samples of 30 ml (9 x 106 cells) were
removed from A and B culture pairs throughout
the experiment for analysis of 75K protein. The
A cultures (no Ara C) were sampled also for
assay of late virion proteins by the complement
fixation test. The kinetics of accumulation of
75K protein in A cultures are presented in Fig.
4A. The synthesis of 75K protein in the control
A culture (not treated with cycloheximide) ex-
hibited again the arrest of 75K protein synthe-
sis. After release from inhibition, the cyclohexi-
mide-treated A culture exhibited a more rapid
rate of accumulation ofthe 75K protein as com-
pared with the control A culture. However, a
somewhat faster onset of arrest was observed,
resulting in a lower final titer. The time of
arrest in both A cultures coincided with the
onset of synthesis of late virion proteins, meas-
ured by CF. In contrast, no arrest in synthesis
of the 75K protein was observed in the B cul-
ture released from cycloheximide and then
treated with Ara C immediately after release.
Again, the released culture exhibited a some-
what faster initial rate of accumulation as com-
pared with the parallel B culture that was not
treated with cycloheximide.
Partition of the 75K protein between cyto-
plasm and nucleus. The cytoplasmic fraction
from Ara C-treated infected cells harvested at
24 h postinfection is routinely used for the puri-
fication of the 75K protein. Unlike the nuclear
fraction, chromatography of the cytoplasmic
fraction on a DNA-cellulose column yields al-
most pure labeled 75K protein (17). It was of
interest to determine the kinetics of synthesis
and the partition of 75K protein in the cytoplas-
mic and nuclear fractions. Infected cells were
sampled at various times after infection, and
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FIG. 3. Synthesis of 75K protein in Ad2-infected
KB cells in the presence and absence of Ara C. A
suspension culture ofKB cells was infected with 200
PFU ofAd2 per cell, divided into two portions, and
maintained at 300,000 cellslml in Eagle minimal
essential medium containing 5% horse serum. Ara C
was added to final concentration of25 pg/ml at 1 h
postinfection to one culture. Samples (30 ml) were
removed at the indicated times, centrifuged, washed
with PBS, and resuspended in 1 ml ofPBS contain-
ing 1% Triton X-100. Cell suspensions were soni-
cated, clarified, and assayed for 75K protein by the
RIPI assay. Symbols: 0, infected culture, no drug;
*, infected culture treated with Ara C.
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FIG. 4. Synthesis of 75K protein and virion proteins in Ad2-infected KB cells after release from a
cycloheximide block in the absence (A) and the presence (B) ofAra C. (A) A suspension culture ofKB cells was
infected and divided into two. One culture received 25 pg ofcycloheximide per ml at 2 h postinfection, and the
other culture served as control. Both cultures were centrifuged at 9 h postinfection, washed twice with warm
medium, and further incubated at 37 C. Samples (30 ml) were removed from each culture at the indicated
times, and extracts were prepared and assayed for 75K protein content by the RIPI assay. Ten-milliliter
samples were removed also for virion protein assay by the complement fixation test. (B) A suspension culture
ofKB cells was infected and divided into two portions. One culture received 25 pg ofAra C per ml at 1 h
postinfection, and the second received 25 pg ofcycloheximide per ml at 2 h postinfection. Both cultures were
centrifuged at 9 h postinfection, washed twice with warm medium containing 25 pg ofAra C per ml, and
further incubated in medium containing 25 pg ofAra C per ml. Samples (30 ml) were removed and extracts
were prepared and assayed for 75K protein by the RIPI assay. 75K protein titer: (A) 0, No drug; 0,
cycloheximide treated (2 to 9 h). (B) 0, Ara C (1 to 24 h); *, cycloheximide (2 to 9 h), Ara C (9 to 24 h). Virion
protein titer: A, No drugs; A, cycloheximide treated.
the cytoplasmic and nuclear fractions were pre-
pared as described in Materials and Methods.
The accumulation of75K protein in cytoplasmic
and nuclear fractions ofuntreated infected cells
(Fig. 5A) and Ara C-treated cells (Fig. 5B)
showed the same overall kinetics observed for
whole cells (Fig. 3). There was some lag in the
appearance of the 75K protein in the nucleus as
compared with the cytoplasm, and the amount
of 75K in the cytoplasm always exceeded that
present in the nuclear fraction, except for late
times in Ara C-treated cultures.
DISCUSSION
Several investigations have identified early
and late adenovirus-specific polypeptides in in-
fected human cells by using sodium dodecyl
sulfate-polyacrylamide gel electrophoresis of
extracts of infected cells labeled with
[35S]methionine (1, 2, 9, 14, 15, 20). Early virus-
specific protein synthesis was detected starting
at 2.5 to 4 h postinfection, and maximum rates
of synthesis occurred at 6 to 12 h postinfection.
A gradual cessation was observed at later
times, and a "switch-over" to late virion protein
synthesis occurred at 12 to 16 h postinfection.
The electrophoretic study of 75K protein,
termed ICSP3 or E, by Russel et al. (14, 15) or
Maizel et al. (9, 20), respectively, was compli-
cated by the presence of a host protein band
that migrated close to the 75K protein band (9,
20). The present study, measuring 75K protein
synthesis by a different method, is consistent
with the general pattern of early adenovirus
protein synthesis that was previously observed
by gel analyses. The method used in our study
has the advantage that it accurately measures
the net accumulation ofimmunologically active
protein molecules and is not influenced by pos-
sible variations in the equilibration and con-
centration of radioactive amino acid pools and
by the background of similarly migrating host
proteins. By immunological assay, we observed
an early synthesis of 75K protein that is appar-
ently influenced by later events in the viral
replication cycle. The synthesis of 75K protein
occurred from 4 to 11 h postinfection, with an
arrest at 11 h that coincided with the onset of
virion protein synthesis. However, the synthe-
sis of the 75K protein continued without arrest
J. VIROL.
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if the synthesis of viral DNA and consequently
late proteins was inhibited. Some investigators
have observed by gel electrophoresis a residual
low level of synthesis of 75K protein at late
times postinfection. This synthesis could be due
to a certain degree of asynchrony in infection.
Alternatively, since the RIPI test measures net
accumulation of immunologically reactive mol-
ecules rather than the rate of synthesis, we
cannot completely rule out the existence of a
residual level of synthesis. The arrest in accu-
mulation of75K protein observed in the present
study can, therefore, reflect a steady-state level
whereby residual synthesis is masked by the
inactivation of some existing 75K protein.
Progeny viral DNA synthesis is blocked in
Ad2-infected cells treated with cycloheximide
early after infection (8), leading to the accumu-
lation of five times as much early viral mRNA
in uninhibited cells (12). We do not know
whether the viral mRNA that codes for the 75K
protein is increased in amount by this proce-
dure. Release from a cycloheximide block pro-
duces an overall decrease in the rate of synthe-
sis of host polypeptides and increase in the
synthesis of several early adenovirus-specific
polypeptides, as measured by gel electrophore-
sis ofextracts ofcells pulse labeled immediately
after release from inhibition (M. Harter, G.
Shanmugam, and M. Green, in preparation).
By the RIPI assay, which measures the actual
quantity of 75K protein, we observed an ini-
tially accelerated accumulation of 75K mole-
cules after release from cycloheximide, but the
accelerated rate was not maintained even in
cells treated with Ara C to prevent arrest.
The gene coding for the 75K protein is located
in EcoRI restriction fragment B (Grodzicker,
Anderson, and Sambrook, personal communi-
cation). A 19 to 20S early mRNA mapped in this
region (3) that is H-strand specific (W. Buett-
ner, S. Veres-Molnar, and M. Green, manu-
script in preparation) has the appropriate cod-
ing capacity for a 75,000-dalton polypeptide and
is a class I early mRNA (3) by the nomenclature
of Lucas and Ginsberg (10); i.e., it is absent or
greatly reduced in amount at 18 h postinfection.
The arrest in 75K synthesis cannot be ex-
plained by the expected normal rate of decay of
mRNA, but could be due to (i) more effective
competition for available ribosomes by abun-
dant late mRNA species or (ii) inhibition by
late virion or virus-coded proteins. Inhibition of
viral DNA synthesis by Ara C may allow con-
tinued transcription of the mRNA for 75K pro-
tein and/or the inhibition of synthesis of late
virion proteins may prevent competition and/or
regulation.
Regulated synthesis of virus-specific early
proteins that is linked to DNA synthesis has
been described in several other DNA virus sys-
tems. For example, the synthesis of phage T4-
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FIG. 5. Partition of 75K protein in cytoplasmic and nuclear fractions ofAd2-infected cells in the absence
(A) and presence (B) ofAra C. A culture ofKB cells was infected and divided into two portions. One culture
received 25 pg ofAra C per ml at 1 h postinfection, and the second culture was untreated. Samples (30 ml)
were removed at the indicated times, washed, and resuspended in PBS containing 1% Triton X-100. Nuclear
and cytoplasmic fractions were separated and assayed for 75K protein by the RIPI assay. Symbols: 0,
Cytoplasmic fractions; 0, nuclear fraction.
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coded early enzymes ceases at 10 to 12 min after
infection. When phage DNA synthesis is in-
hibited or delayed, such as by infection with
phage T4 amber mutants or UV-irradiated
phage, early enzyme synthesis continues well
beyond 10 to 12 min. The amount of enzymes at
60 min after infection may reach levels four to
five times greater than after infection with
wild-type T4 phage (21). The synthesis of poxvi-
rus-coded thymidine kinase, an "immediate"
early protein, is also abruptly inhibited early
after infection. Studies using inhibitors have
suggested that a viral gene product synthesized
after uncoating of virus (perhaps a "delayed"
early protein) turns off the synthesis of thymi-
dine kinase (11). The synthesis of herpesvirus
type 1-specific polypeptides is coordinately reg-
ulated and sequentially ordered. Three classes,
a, f3, and y, were described according to their
times of synthesis. The synthesis ofone or more
functional a polypeptides is necessary to
"switch on" the synthesis of if or y polypeptides,
and one or more 83 or y polypeptides "switch off'
the synthesis of a polypeptides (7).
The intracellular localization ofvirus-specific
early proteins is of interest since it may provide
clues regarding function. We have shown that
the 75K protein is present in both the cyto-
plasm and nucleus, and the kinetics of accumu-
lation provide guidelines for the isolation of
maximum yields for further studies. However,
conclusions regarding intracellular localization
are subject to the usual cautions concerning
leakage from the nucleus during cell fractiona-
tion. The lag in appearance of 75K protein in
the nucleus and the association of 75K protein
with rapidly sedimenting structures in the cy-
toplasmic and nuclear fractions (Gilead et al.,
unpublished data) suggest that the intracellu-
lar localization deduced from biochemical frac-
tionation may be valid. Immunoflourescence
studies with fixed-cell preparations using anti-
body to purified 75K protein may resolve this
important point.
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